Wesbanco Bank Inc. Acquires Shares of 184,724 Allscripts Healthcare Solutions Inc (MDRX)

Wesbanco Bank Inc. acquired a new stake in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 184,724 shares of the software maker’s stock, valued at approximately $2,281,000. Wesbanco Bank Inc. owned 0.10% of Allscripts Healthcare Solutions as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of MDRX. Fisher Asset Management LLC boosted its stake in shares of Allscripts Healthcare Solutions by 117.6% in the first quarter. Fisher Asset Management LLC now owns 5,192,457 shares of the software maker’s stock valued at $64,127,000 after purchasing an additional 2,806,220 shares during the period. Redmile Group LLC purchased a new position in shares of Allscripts Healthcare Solutions in the fourth quarter valued at approximately $25,762,000. Silvercrest Asset Management Group LLC boosted its stake in shares of Allscripts Healthcare Solutions by 26.5% in the first quarter. Silvercrest Asset Management Group LLC now owns 4,438,241 shares of the software maker’s stock valued at $54,812,000 after purchasing an additional 929,720 shares during the period. Fort Washington Investment Advisors Inc. OH boosted its stake in shares of Allscripts Healthcare Solutions by 72.9% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 1,874,300 shares of the software maker’s stock valued at $23,148,000 after purchasing an additional 790,000 shares during the period. Finally, UBS Group AG boosted its stake in shares of Allscripts Healthcare Solutions by 734.9% in the first quarter. UBS Group AG now owns 894,859 shares of the software maker’s stock valued at $11,051,000 after purchasing an additional 787,681 shares during the period.

A number of research analysts recently issued reports on the stock. JPMorgan Chase & Co. assumed coverage on shares of Allscripts Healthcare Solutions in a research note on Tuesday, April 24th. They issued an “overweight” rating and a $16.00 price target for the company. ValuEngine upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Thursday, May 17th. Maxim Group reiterated a “buy” rating and issued a $18.00 price target on shares of Allscripts Healthcare Solutions in a research note on Friday, May 4th. BidaskClub downgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research note on Wednesday, June 13th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $18.00 price target on shares of Allscripts Healthcare Solutions in a research note on Tuesday, March 6th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and thirteen have given a buy rating to the company’s stock. Allscripts Healthcare Solutions presently has a consensus rating of “Buy” and an average price target of $16.20.

In related news, Director Michael Klayko acquired 4,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Wednesday, June 13th. The stock was acquired at an average price of $12.52 per share, for a total transaction of $50,080.00. Following the transaction, the director now owns 117,315 shares of the company’s stock, valued at $1,468,783.80. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Brian Farley sold 5,000 shares of Allscripts Healthcare Solutions stock in a transaction on Thursday, June 14th. The shares were sold at an average price of $12.23, for a total transaction of $61,150.00. Following the completion of the transaction, the executive vice president now directly owns 247,673 shares in the company, valued at $3,029,040.79. The disclosure for this sale can be found here. 0.75% of the stock is currently owned by insiders.

Shares of NASDAQ:MDRX opened at $12.49 on Thursday. The company has a market cap of $2.23 billion, a PE ratio of 26.57, a P/E/G ratio of 1.67 and a beta of 1.26. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 1.53. Allscripts Healthcare Solutions Inc has a twelve month low of $10.78 and a twelve month high of $16.13.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, May 3rd. The software maker reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.01). The company had revenue of $518.60 million for the quarter, compared to analysts’ expectations of $527.34 million. Allscripts Healthcare Solutions had a positive return on equity of 7.80% and a negative net margin of 11.34%. The firm’s quarterly revenue was up 24.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.13 EPS. equities research analysts forecast that Allscripts Healthcare Solutions Inc will post 0.55 EPS for the current year.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply